Trial site
Private Medical Institution "Euromedservice"
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Head and neck cancer2 trials
- Ovarian cancer2 trials
- Prostate cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- and 1 more
- Phase
- Phase 39 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting7 trials
- Completed5 trials
- Terminated1 trial
- Lead sponsor
- Pfizer10 trials
- R-Pharm2 trials
- Yuhan Corporation1 trial
Running trials
Active, not recruiting
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Closed trials
Completed
Completed
Completed
Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies
Completed
Terminated
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Site data: ClinicalTrials.govUpdated 18 Nov 2026